gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females
Clinical trial NCT00133497 · COMPLETED
Trial details
- NCT number
- NCT00133497
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2013-06-01
- Enrollment
- 409
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.